Toxicity Is Not Associated with Age or Comorbidity Score in a Randomised Study of Oral Fludarabine and Cyclophosphamide and IV Rituximab (FCR) As First-Line Therapy of Fit, Elderly Patients with Chronic Lymphocytic Leukemia (CLL)Stephen P. Mulligan, Bryone J. Kuss, Maya Latimer et al.|Blood|2014Cited by 5
Quality of Life in Fit Elderly Patients with Chronic Lymphocytic Leukemia (CLL) Receiving Oral Fludarabine-Based Regimens As First Line Therapy: Australasian Leukaemia and Lymphoma Group (ALLG) CLL5 TrialSuneet Sandhu, Stephen P. Mulligan, Devinder Gill et al.|Blood|2015Cited by 0